MONDAY, Oct. 14, 2024 (HealthDay News) — A simple tweak in available vial sizes of the breakthrough Alzheimer’s drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims. About 6% of Leqembi (lecanemab) is discarded because patients are frequently prescribed doses lower than theContinue Reading

THURSDAY, Sept. 26, 2024 (HealthDay News) — Brain damage that veterans suffered from flying shrapnel has provided a major clue that could lead to better treatment for post-traumatic stress disorder (PTSD), a new study says. Veterans who suffered shrapnel damage connected to their amygdala, the fear center of the brain,Continue Reading